
Amidst controversy, the FDA finally approved the controversial prostate cancer therapy. Hopes are high that Provenge represents the first in a long line of effective immunotherapeutics.

Your AI-Trained Oncology Knowledge Connection!


Published: December 6th 2010 | Updated: